How will lung cancer screening and lung nodule management change the diagnostic and surgical lung cancer landscape?

Georgia Hardavella*, Armin Frille, Roberto Chalela, Katherina B. Sreter, Rene H. Petersen, Nuria Novoa, Harry J. de Koning

*Corresponding author for this work

Research output: Contribution to journalReview articlePopular

Abstract

INTRODUCTION: 

Implementation of lung cancer screening, with its subsequent findings, is anticipated to change the current diagnostic and surgical lung cancer landscape. This review aimed to identify and present the most updated expert opinion and discuss relevant evidence regarding the impact of lung cancer screening and lung nodule management on the diagnostic and surgical landscape of lung cancer, as well as summarise points for clinical practice. 

METHODS: 

This article is based on relevant lectures and talks delivered during the European Society of Thoracic Surgeons-European Respiratory Society Collaborative Course on Thoracic Oncology (February 2023). Original lectures and talks and their relevant references were included. An additional literature search was conducted and peer-reviewed studies in English (December 2022 to June 2023) from the PubMed/Medline databases were evaluated with regards to immediate affinity of the published papers to the original talks presented at the course. An updated literature search was conducted (June 2023 to December 2023) to ensure that updated literature is included within this article. 

RESULTS: 

Lung cancer screening suspicious findings are expected to increase the number of diagnostic investigations required therefore impacting on current capacity and resources. Healthcare systems already face a shortage of imaging and diagnostic slots and they are also challenged by the shortage of interventional radiologists. Thoracic surgery will be impacted by the wider lung cancer screening implementation with increased volume and earlier stages of lung cancer. Nonsuspicious findings reported at lung cancer screening will need attention and subsequent referrals where required to ensure participants are appropriately diagnosed and managed and that they are not lost within healthcare systems. 

CONCLUSIONS: 

Implementation of lung cancer screening requires appropriate mapping of existing resources and infrastructure to ensure a tailored restructuring strategy to ensure that healthcare systems can meet the new needs.

Original languageEnglish
JournalEuropean respiratory review : an official journal of the European Respiratory Society
Volume33
Issue number172
DOIs
Publication statusPublished - 1 Apr 2024

Bibliographical note

Publisher Copyright:
Copyright ©The authors 2024.

Fingerprint

Dive into the research topics of 'How will lung cancer screening and lung nodule management change the diagnostic and surgical lung cancer landscape?'. Together they form a unique fingerprint.

Cite this